<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>AAVS_MH20150120070140-R1_ Andonova</title>
		<link href="http://nexusacademicpublishers.com/uploads/cssfiles/AAVS_MH20150120070140-R1_ Andonova.css" rel="stylesheet" type="text/css" />
	</head>
    <style> 
.pt{
	background-color:#BDF;
	border-top-style:solid;
	
	border-top-color:#d3d1d1;
	border-top-width: 1px;
	border-bottom-style: solid;
	
	border-bottom-color:#d3d1d1;
	border-bottom-width: 1px;
	height:90px;
	}
	  
.img_display{
	float:left;
	padding:5px;
	
	}
	.img_text{ padding:10px;
		
		}
		
		.Txt_Dis{
			padding-right:20px;
			}
</style>

<body id="AAVS_MH20150120070140-R1_-Andonova" lang="en-GB">
		<div class="Basic-Text-Frame">
			<p class="Type-of-Article">&nbsp;</p>
			<p class="Type-of-Article"><span class="CharOverride-1">Research Article</span></p>
	</div>
		<div class="Basic-Text-Frame">
			<p class="title- ParaOverride-1">&nbsp;</p>
			<p class="title- ParaOverride-1">Evaluation of Nuclear Factor Kappa Beta, Nitric Oxide and Blood Neutrophil/Lymphocyte Ratio as Biomarkers of Inflammatory Response and Complementary Therapy in Dogs with Experimental Skin <i>Pseudomonas aeruginosa</i> Infection </p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Authors ParaOverride-1">&nbsp;</p>
			<p class="Authors ParaOverride-1"><span class="CharOverride-3">Maria Andonova</span><span class="CharOverride-4">1*</span><span class="CharOverride-3">, Valentina Urumova</span><span class="CharOverride-4">2</span><span class="CharOverride-3">, Dimitrichka Dimitrova</span><span class="CharOverride-4">3</span><span class="CharOverride-3">, Evgeni Slavov</span><span class="CharOverride-4">1</span><span class="CharOverride-3">, Petko Dzhelebov</span><span class="CharOverride-4">1</span><span class="CharOverride-3">, Tsvetan Chaprazov</span><span class="CharOverride-4">4</span><span class="CharOverride-3">, Ivan Borissov</span><span class="CharOverride-4">4</span></p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Affiliations ParaOverride-1"><span class="CharOverride-5">1</span>Department of General and Clinical Pathology; <span class="CharOverride-5">2</span>Department of Veterinary Microbiology, Infectious and Parasitic Diseases; <span class="CharOverride-5">3</span>Department of Pharmacology, Animal Physiology and Physiological Chemistry; <span class="CharOverride-5">4</span>Department of  Veterinary Surgery, Faculty of Veterinary Medicine, Trakia University, Stara Zagora 6000, Bulgaria.</p>
		</div>
		<div>
			<p class="Abstract ParaOverride-1">&nbsp;</p>
			<p class="Abstract ParaOverride-1"><span class="CharOverride-6">Abstract</span> | <span>The optimisation of strategies for control of</span><span class="CharOverride-6"> </span><span class="CharOverride-7">Pseudomonas aeruginosa</span><span> skin infections in dogs includes minimization of induced hyper-inflammation. We aimed at monitoring changes in serum nuclear factor kappa B (NF-</span><span class="CharOverride-8">к</span><span>B) and nitric oxide (NO) concentrations, and blood neutrophil/lymphocyte ratio (N/L ratio), to evaluate their potential as inflammatory markers throughout the course of therapy in canine skin infection experimentally induced by </span><span class="CharOverride-7">P. aeruginosa.</span><span> A complementary therapy including antibiotic against the pathogen and NF-</span><span class="CharOverride-8">к</span><span>B targeted host modulatory therapy by parthenolide from the phytopreparation Feverfew was applied. NF-</span><span class="CharOverride-8">к</span><span>B was determined by ELISA kit. The NO assay was based on the</span><span class="CharOverride-9"> g</span><span>riess reaction. The N/L ratio was calculated on the basis of CBC counts. The infection was induced by </span><span class="CharOverride-7">P. aeruginosa</span><span> (1×10</span><span class="CharOverride-5">8 </span><span>CFU/mL) injected s.c. to 20 male dogs. Four experimental groups were formed (0 – untreated dogs and three treated</span> <span>groups: I – with antibiotic; II – with Feverfew and III – with antibiotic and Feverfew) and one control group. The results showed that NF-</span><span class="CharOverride-8">к</span><span>B in group 0 was significantly higher than those in controls on hour 24 (p=0.0103), hour 48 (p=0.0001), hour 72 (p=0.0505), day 7 (p=0.0114), and day 10 (p=0.0094). The treatment with Feverfew (group II and III) achieved an efficient control on NF-</span><span class="CharOverride-8">к</span><span>B. In groups I and II, biphasic increase in NO was observed, associated with the early – hour 4 (p=0.00007 for group I; p=0.0001 for group II vs. baseline) and late – day 14 (p=0.0092 for group II vs. controls) stage of infection development. By hour 24, N/L ratio in these groups increased (p=0.005 and p=0.0104 for groups I and II respectively vs. baseline). The established changes were generalised signs of inflammatory response accompanied by fever on hour 4 in infected dogs (p=0.0005 for group 0; p=0.0008 - I; p=0.0002–II; p=0.0047-III vs. controls).</span></p>
		  <p class="Abstract ParaOverride-1">&nbsp;</p>
			<p class="Abstract ParaOverride-1"><span class="CharOverride-6">Keywords </span>| <span class="CharOverride-7">Pseudomonas aeruginosa</span><span>, Canine</span><span class="CharOverride-7"> </span><span>skin infection, Inflammatory biomarkers, Therapy, Feverfew</span></p>
		  <p class="Abstract ParaOverride-1">&nbsp;</p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Editor----Citation"><span class="CharOverride-6">Editor</span> | Kuldeep Dhama, Indian Veterinary Research Institute, Uttar Pradesh, India.</p>
			<p class="Editor----Citation"><span class="CharOverride-6">Received</span> | January 20, 2015; <span class="CharOverride-6">Revised</span> | February 12, 2015; <span class="CharOverride-6">Accepted </span>| February 13, 2015; <span class="CharOverride-6">Published</span> | February 20, 2015&#9;&#9;</p>
			<p class="Editor----Citation"><span class="CharOverride-6">*Correspondence </span>| Maria Andonova, Trakia University, Stara Zagora, Bulgaria; <span class="CharOverride-6">Email:</span> andonova_m@yahoo.com</p>
			<p class="Editor----Citation"><span class="CharOverride-6">Citation</span> | Andonova M, Urumova V, Dimitrova D, Slavov E, Dzhelebov P, Chaprazov T, Borissov I (2015). Evaluation of nuclear factor kappa beta, nitric oxide and blood neutrophil/lymphocyte ratio as biomarkers of inflammatory response and complementary therapy in dogs with experimental skin <span class="CharOverride-25">Pseudomonas aeruginosa</span> infection . Adv. Anim. Vet. Sci. 3(3): 174-182.  </p>
			<p class="Editor----Citation"><span class="CharOverride-6">DOI </span>| <a href="http://dx.doi.org/10.14737/journal.aavs/2015/3.3.174.182"><span class="Hyperlink">http://dx.doi.org/10.14737/journal.aavs/2015/3.3.174.182</span></a></p>
			<p class="Editor----Citation"><span class="Editor---Citation CharOverride-6">ISSN (Online)</span> | 2307-8316; <span class="Editor---Citation CharOverride-6">ISSN (Print)</span> | 2309-3331</p>
			<p class="Editor----Citation"><span class="CharOverride-6">Copyright</span> © 2015 Andonova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
		</div>
		<div class="Basic-Text-Frame">
			<p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Heading-1--Introduction----">&nbsp;</p>
		  <p class="Heading-1--Introduction----">INTRODUCTION</p>
			<p class="Caps-on-First-Para ParaOverride-1">&nbsp;</p>
			<p class="Caps-on-First-Para ParaOverride-1"><span class="_idGenDropcap-1">P</span><span class="CharOverride-7">seudomonas </span><span class="CharOverride-7">aeruginosa</span> is an opportunistic pathogen, which attacks the body after breakthrough of skin immune protection (<a href="#Kipnis-E--Sawa-T--Wiener-Kronosh-J--2006"><span class="Hyperlink">Kipnis et al., 2006</span></a>). It is a skin commensal in dogs and causes skin infections that are difficult to control. Antibiotic therapy is problematic, due to the high bacterial variability, biofilm forming and swift building of resistance to antibiotics (<a href="#Breidenstein-E--Fuente-Ninez-C--Hancock-R--2011"><span class="Hyperlink">Breidenstein et al., 2011</span></a>). The challenge with <span class="CharOverride-7">P. aeruginosa</span> infections is also due to the heterogenous nature of occurring disturbances affecting systemic defense - innate immunity (<a href="#Lavoie-EG--Wangdi-T--Kazmierczak-B--2011"><span class="Hyperlink">Lavoie et al., 2011</span></a>) and adaptive immunity (<a href="#Sprucek-F--Toman-M--Faldyna-M--Svoboda-M--2007"><span class="Hyperlink">Sprucek et al., 2007</span></a>). <span class="CharOverride-7">P. aeruginosa</span> induces a strong inflammatory response (<a href="#Kumar-H--Kawai-T--Akira-S--2011"><span class="Hyperlink">Kumar et al., 2011</span></a>) through activation of many skin cell elements, enhanced synthesis of pro-inflammatory cytrokines, strong neutrophil infiltration (<a href="#Mantovani-A--Cassatella-MA--Costantini-C--Jaillon-S--2011-."><span class="Hyperlink">Mantovani et al., 2011</span></a>). The inflammation process requires great amount of metabolic energy and provokes a systemic response manifested with fever, metabolic and functional alterations (<a href="#Lindestam-AC--2010"><span class="Hyperlink">Lindestam, 2010</span></a>). In a clinical setting, the thorough control on inflammatory response strength is very important because the uncontrolled initial inflammation may overshoot and result in tissue damage and immune dysfunction. This necessitates to identify biomarkers, which could assess the development of inflammation, with predictive power and offering possibilities for evaluation of applied treatment. Some of them are haematological and blood biochemical indices (<a href="#Andonova-M--Urumova-V--Petkova-B--Slavov-E--Dzhelebov-P--Chaprazov-T--Roidev-R----Borissov-I--2014-"><span class="Hyperlink">Andonova et al., 2014</span></a>), cytokines (<a href="#Lacour-AG--Gervaix-A--Zamora-SA--Vadas-L--Lombard-PR--Dayer-JM--Suter-S--2001"><span class="Hyperlink">Lacour et al., 2001</span></a>), although observed changes are only short-term. Furthermore, the search for effective therapy has recently become most intensive (<a href="#Angus-DC--2011-"><span class="Hyperlink">Angus, 2011</span></a>). The optimisation of strategies for eradication of <span class="CharOverride-7">P. aeruginosa</span> requires a complementary therapy including antibiotic against the pathogen and host modulatory therapy to correct impaired key signalling pathways. NF-<span class="CharOverride-8">к</span>B is a target of host modulatory therapy (<a href="#Vitiello-M--Galdiero-M--Finamore-E--Galdiero-S--Galdiero-M--2012"><span class="Hyperlink">Vitiello et al., 2012</span></a>). NF-<span class="CharOverride-8">к</span>B controls genes, a major part of which are related to inflammatory process (<a href="#Tilstra-JS--Clauson-CL--Niedernhofer-LJ--Robbins-PD--2011-."><span class="Hyperlink">Tilstra et al., 2011</span></a>). <a href="#Tak-PP--Firestein-GS--2001"><span class="Hyperlink">Tak and Firestein (2001)</span></a><span class="Hyperlink"> </span>and <a href="#Rahman-M--McFadden-G--2011"><span class="Hyperlink">Rahman and McFadden (2011)</span></a> consider NF-kB as a biomarker of inflammation. <a href="#Xie-QW--Kashiwabara-Y--Nathan-C--1994"><span class="Hyperlink">Xie et al. (1994)</span></a> comment on the role of NF-kB in induction of nitric oxide (NO) synthesis. <a href="#Yang-Q--Ghose-P--Ismaila-N--2013"><span class="Hyperlink">Yang et al. (2013)</span></a>, <a href="#Celikbilek-A--Ismailogullari-S--Zararsiz-G--2014-."><span class="Hyperlink">Celikbilek et al. (2014)</span></a> and <a href="#Farah-R--Khamisy-Farah-R--2014-"><span class="Hyperlink">Farah and Khamisy-Farah (2014)</span></a> outlined the neutrophil/lymphocyte ratio (N/L ratio) is a simple marker of inflammation. Many efforts have been focused on identifying substances, which can prevent the inflammatory process at the very early stage of gene expression. <a href="#Paur-I--Austena-LM--Blomhoff-R--2008"><span class="Hyperlink">Paur et al. (2008) </span></a>reported that plant extracts are efficient modulators of NF-<span class="CharOverride-8">к</span>B. Several groups have reported the effects of parthenolide (natural product, a sesquiterpene lactone isolated from extracts of <span class="apple-converted-space CharOverride-7">Tanacetum parthenium</span><span class="apple-converted-space"> - Feverfew)</span> on NF-<span class="CharOverride-8">к</span>B inhibition. <a href="#Koprowska-K--Czyz-M--2010-."><span class="Hyperlink">Koprowska and Czyz (2010)</span></a> outlined the molecular mechanisms of parthenolide action, whereas <a href="#Mathema-VB--Young-Sang-K--Balkrishna-CT--Mika-S--2012-."><span class="Hyperlink">Mathema et al. (2012)</span></a> are focused on anti-inflammatory properties of this natural product.  </p>
		  <p class="Caps-on-First-Para ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The multi-pharmacological potential of parthenolide, the limited clinical data about dosage, onset and duration of application and its efficacy as anti-inflammatory agent in dogs, the possibility for utilisation of easy-to-detect inflammation biomarkers in a clinical setting, and tests of new therapeutic schedules in skin <span class="CharOverride-7">P. aeroginosa</span> infection based on the pathogenetic approach have provoked our scientific interest.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">We designed and performed an <span class="CharOverride-7">in vivo</span> study in dogs with experimental <span class="CharOverride-7">P. aeruginosa</span> model of skin infection aimed at monitoring changes in serum NF-<span class="CharOverride-8">к</span>B and NO concentrations, and blood N/L ratios, to evaluate their potential as inflammatory markers throughout the course of agent- or/and  host-targeted therapy for infection control.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">MATERIALS AND METHODS</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Heading-2--History-in-MM-">Animals</p>
			<p class="Body-Text ParaOverride-1">Twenty-five clinically healthy adult mixed-breed male dogs from a licensed vivarium, 2 to 5 years of age were used. Prior to the experiment they were treated with antiparasitic shampoo Friskies (Milano–Italia), orally with praziquantel/abamectin (Prazimec D–Biovet Ltd, Peshtera, Bulgaria)  against helminths at a dose of 1 tablet/10 kg body weight and with the combination permethrin/carbaryl against ectoparasites (Tapilan-B <span class="CharOverride-11">−</span> Dorvert, Israel). The dogs were housed in the vivarium of the Functional Pathology and Immunology Unit at the Faculty of Veterinary Medicine under the following conditions: mixed light regimen (light/dark), air humidity 50-60% and air temperature 15-21<span class="CharOverride-5">o</span>C. They were fed dry canine food (Canil Social Gouomarc H <span class="CharOverride-11">−</span> Brazil) and had a free access to drinking water. Dogs were walked twice daily.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">Experiments were performed with strict compliance with animal ethics standards (protocol 16/2010 of the Ethical Committee of National Veterinary Service; permit No. 37). All dogs included in the trial were treated appropriately; the clinical and blood laboratory indices were regularly analysed. The health and microbiological status of dogs were strictly monitored. The dogs received the best possible veterinary care from experienced personnel. After the end of the trial, they did not pose any risk for the environment, public health and their owners. <span class="CharOverride-7"> </span></p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-">Bacterial Strain</p>
			<p class="Body-Text ParaOverride-1">A canine field <span class="CharOverride-7">P. aeruginosa </span>isolate typed by the BBL Crystal semi-automated identification system (Becton Diskinson, USA) and kit for Gram-negative bacteria and non-fermentative bacteria was used. The kit contains thirty enzymatic tests for biochemical identification of bacteria. The following characteristics of <span class="CharOverride-7">P. aeruginosa</span> were used for presumptive identification: growth on MacConkey agar; pyoverdin production; oxidase test; growth at 5<span class="CharOverride-5">o</span>C and at 42<span class="CharOverride-5">o</span>C; oxidation of glucose, lactose, maltose; arginine dehydrolase production; urease production; reduction of nitrate to nitrite; urease production; gelatin hydrolisation.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-">Experimental Design</p>
			<p class="Body-Text ParaOverride-1">Experimental skin infection model was performed through subcutaneous injection of <span class="CharOverride-7">P. aeruginosa</span> suspension in sterile saline into a depilated area in the neck region of dogs (n=20). We used a bacterial culture in stationary phase with density corresponding to 1×10<span class="CharOverride-5">8 </span>CFU/mL prepared nephelometrically according to the MacFarland standard (<a href="#Quinn-PJ--Carter-ME--Markey-BK--Carter-GR--1999-"><span class="Hyperlink">Quinn et al., 1999</span></a>). Infected animals were further divided into groups. Those from group 0 (n=5) were injected only with <span class="CharOverride-7">P. aeruginosa.</span> Dogs from group I (n=5) were treated s.c. with 2.5% Enrofloxacin solution (Syvaquinol 25 injectable <span class="CharOverride-11">−</span> Syva laboratorios, Spain) on post infection hour 48. The antibiotic therapy lasted 10 consecutive days at a dose of 5 mg/kg. Dogs from group II (n=5) were treated with Feverfew (standardised extract, active principle parthenolide 0.7% <span class="CharOverride-11">−</span> Nature’s Way, USA), by application of 1 capsule at 12-hour intervals. The treatment per os, began on post infection hour 4 and continued for 6 days. The purpose of applying this natural product in the early stage of skin infection was to control the inflammation response strength (host modulatory therapy). Dogs from group III (n=5) were treated with the combination of antibiotic and Feverfew. The schedule consisted of daily oral intake of two capsules Feverfew for 6 days and the s.c. antibiotic therapy with Enrofloxacin started on the 48<span class="CharOverride-5">th</span> hour post infection and lasted 10 days. The control group (n=5) was s. c. injected with saline into a depilated area of the neck. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-">Collection of Blood Samples</p>
			<p class="Body-Text ParaOverride-1">Blood samples were obtained from <span class="CharOverride-7">v. cephalica antebrachii</span> by means of Venflon cannulae (Vygon GmbH &amp; Co., Germany) prior to the infection – hour 0 and on post infection hours 4, 24, 48, 72 and days 7, 10 and 14. All blood samples were collected in the morning before feeding (8.00<span class="CharOverride-11">−</span>8.30 AM) to eliminate circadian influences in EDTA-anticoagulated and serum separator tubes. Samples were allowed to clot for two hours at room temperature before centrifugation for 15 min at 1000×g. Sera were removed, assayed immediately (for determination of serum NO concentrations) or aliquoted and stored at <span class="CharOverride-11">−</span>80<span class="CharOverride-5">o</span>C (for determination of NF- <span class="CharOverride-8">к</span>B).</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">Serum concentrations of canine nuclear factor kappa B (NF-<span class="CharOverride-8">к</span>B) were determined by a commercial ELISA test kit (cat. No E1824c, USCN LIFE, China). This assay recognises recombinant and natural canine NF-<span class="CharOverride-8">к</span>B without significant cross-reactivity or interference. The detection range was from 0.312 to 20 ng/m<span class="CharOverride-9">l.</span> </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">Serum NO was measured as stable end product nitrite according to the method of <a href="#Miranda-K--Espey-MG--Wink-DA--2001-."><span class="Hyperlink">Miranda et al. (2001)</span></a>. Serum samples were deproteinised with cold acetonitrile (1:1). After centrifugation (10 min; 1000×g), supernatants were analysed immediately. The assay is based on the reduction of nitrate by vanadium trichloride combined with detection by the acidic <span class="CharOverride-9">g</span>riess reaction. The diazotisation of sulfanilic acid with nitrite at acidic pH and subsequent coupling with N-(10 naphthyl)-ethylene diamine produced a coloured compound measured spectrophotometrically at 540 nm. The results are presented in µmol/L. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The blood neutrophil to lymphocyte (N/L) ratio was calculated on the basis of CBC counts obtained from the automated cell count analyzer Coulter Electronics, Krefeld, German. <span class="CharOverride-7">  </span></p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-2--History-in-MM-">Statistical Analysis</p>
			<p class="Body-Text ParaOverride-1">Results are presented as mean ± SD. Data was submitted to one-way ANOVA followed by Turkey’s <span class="CharOverride-7">post hoc</span> test by means of statistical software (Graph Pad InStat3;<span class="CharOverride-12"> </span>MedCalc, Belgium). Differences were considered statistically significant at the p&lt;0.05 level. </p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">RESULTS</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The dynamics of NF-<span class="CharOverride-8">к</span>B concentrations depicted in Figure 1 shows similar levels in all experimental dogs on post infection hour 4. However, on post infection hour 24, the animals from group 0 and group I exhibited peaks in NF-<span class="CharOverride-8">к</span>B concentrations, which were statistically significant both vs hour 4 (p=0.0123 and p=0.0128 respectively), and vs controls, groups II and III. Dogs from group 0 maintained significantly higher NF-<span class="CharOverride-8">к</span>B levels even on post infection day 10 compared to controls (p=0.0094), group II (p=0.0265) and group III (p=0.0097). Dogs treated with Feverfew (group II) and Enrofloxacin + Feverfew (group III) did not show any considerable deviations in serum NF-<span class="CharOverride-8">к</span>B throughout the experiment (<a href="#Figure-1-"><span class="Hyperlink">Figure 1</span></a>). This was also observed in dogs from group I (antibiotic therapy), whose NF-<span class="CharOverride-8">к</span>B levels were not substantially altered between post infection days 7 and 10. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">In all infected animals, serum NO increased on post infection hour 4 as compared to baseline, with statistically significant differences in groups I (p=0.00007) and II (p=0.0001) (<a href="#Table-1-"><span class="Hyperlink">Table 1</span></a>). In group III, NO levels were higher both vs controls (p=0.0386). After that time, serum NO concentrations in the group treated with antibiotic declined significantly by post infection hours 24 (p=0.0060); 48 and 72 (p=0.0001) and day 10 (p=0.0064) vs hour 4. Dogs treated with Feverfew (group II) also exhibited a substantial reduction, with minimum value on the 7<span class="CharOverride-5">th</span> day. In these two groups however, NO concentrations increased again at the end of the experiment (day 14) with statistically significant differences between group II vs controls (p=0.0092) and vs group 0 (p=0.0040). At that time, NO levels in other infected dogs (groups 0 and III) were also higher than controls.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">Four hours after s. c. inoculation of <span class="CharOverride-7">P. aeruginosa</span>, N/L ratios in all experimental animals were slightly higher than baseline values (<a href="#Table-2-"><span class="Hyperlink">Table 2</span></a>). In dogs treated with Feverfew (group II), N/L ratios attained a peak on post infection hour 24, which was considerably difference both vs control group (p=0.0082), and group 0 (p=0.028). After that period, N/L ratio in group II were significantly reduced on day 7 (p=0.0358), 10 (p=0.0086) and 14 (p=0.0120) vs hour 24. A similar time course was observed in infected dogs treated with Enrofloxacin (group I) except for the lower peak at hour 24 and the minimum N/L ratio occurring at the 14<span class="CharOverride-5">th</span> day (p=0.0002 vs hour 24; <a href="#Table-2-"><span class="Hyperlink">Table 2</span></a>). </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">On post infection hour 4, rectal temperature (RT) was increased in all experimental groups compared to control (p=0.0005 for group 0, p=0.0008 for group I, p=0.0002 for group II and p=0.0047 for group III) (<a href="#Table-3-"><span class="Hyperlink">Table 3</span></a>). On hour 48, the fever was still present in all groups except for group III.  Another 24 h later, the RT of dogs in group 0 only remained elevated compared to both controls (p=0.0136) and dogs treated with Feverfew+enrofloxacin (p=0.0076). On subsequent experimental time intervals, RT in all groups was within the normal range.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">   </p>
			<p class="Body-Text ParaOverride-1">The described changes in dogs with experimental skin <span class="CharOverride-7">P. aeruginosa </span>infection were accompanied by nonspecific symptoms and signs – inappetance, somnolence associated with fever and were related to the organ involved. At the site of injection, inflammation was detected as early as the 4<span class="CharOverride-5">th</span> hour and on hour 24, round firm non-painful infiltrative oedema, with erythematous plaques have appeared. The area became indurated, and the skin – rough and  crusty (days 7–10). </p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  
			
          <div class="pt" > <a href="http://nexusacademicpublishers.com/uploads/figures/20150220144556.jpg" target="new"><img class="img_display" src="http://nexusacademicpublishers.com/uploads/figures/20150220144556.jpg" width="80" height="80"></a>
            
           <p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-6"><a id="Figure-1-"></a>Figure 1: </span><a href="http://nexusacademicpublishers.com/uploads/figures/20150220144556.jpg">Serum nuclear factor kappa-beta (NF-kB) (ng/mL) in controls, dogs with experimental skin <span class="CharOverride-7">P. aeruginosa</span> infection - group 0 (untreated) and treated: group I (antibiotic), group II (Feverfew); group III (antibiotic+Feverfew)</a></p>
       </div>

		  <p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
		  <p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-14">Values are means ± SD of five dogs in each group. </span></p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-14">Between-group level of significance: </span><span class="CharOverride-10">1</span><span class="CharOverride-14"> p&lt;0.05; </span><span class="CharOverride-10">2</span><span class="CharOverride-14"> p&lt;0.01; </span><span class="CharOverride-10">3</span><span class="CharOverride-14"> p&lt;0.001; </span><span class="CharOverride-10">a</span><span class="CharOverride-14"> – vs control group; </span><span class="CharOverride-10">d</span><span class="CharOverride-14"> – vs group II; </span><span class="CharOverride-10">e</span><span class="CharOverride-14"> – vs group III.</span></p>
			<p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
		  <p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-6"><a id="Table-1-"></a>Table 1: </span>Serum nitric oxide (μmol/L) in controls, dogs with experimental skin <span class="CharOverride-7">P. aeruginosa</span> infection - group 0 (untreated) and treated: group I (antibiotic), group II (Feverfew); group III (antibiotic+Feverfew). Values are means ± SD of five dogs in each group  </p>
			<table width="657" height="536" class="Table-Style-1" id="table-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-5" />
					<col class="_idGenTableRowColumn-6" />
				</colgroup>
				<tbody>
					<tr class="_idGenTableRowColumn-7">
						<td />
						<td />
						<td colspan="4">
							<p class="Basic-Paragraph"><span class="CharOverride-15">Groups</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td />
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">Control</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">0 group               </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">I group                </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">II group                </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">III group        </span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">0h</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">66.6±2.7             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">64.4±10.9            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">56.9±7.8</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">***              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">64.8±4.8</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">*             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">64.4±5.0</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">4 h          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">65.4±2.3              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">71.2±14.8            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">92.2±0.5 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">+++             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">95.8±8.8             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">110.8±41.0 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a1</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">24h          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">65.4±4.8              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">69.8±9.7            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">58.4±20.4 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">++            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">70.2±20.1            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">88.4±21.4</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">48 h         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">64.8±4.7              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">70.6±8.1            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">62.5±9.0  </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">+++                          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">68.0±5.2             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">72.5±21.4</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">72 h         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">66.3±3.9              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">70.5±15.0          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">59.8±10.6            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">81.8±9.2 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">++             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">84.7±41.9</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">7 d           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">64.9±5.0              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">101.4±46.2        </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">76.9±10.4  </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">++           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">55.0±5.5             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">77.4±13.6</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">10 d         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">62.8±4.0              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">81.9±6.9             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">66.5±15.7 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">***§§vv                       </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">85.4±7.8 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">***§§vv•••             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">85.6±21.1</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">14 d         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">63.9±4.6              </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">73.6±14.5           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">87.9±4.8             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">109.9±29.8 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a2b1         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">85.3±20.2</span></p>
						</td>
					</tr>
				</tbody>
			</table>
			<p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-14">Within-group level of significance: * p&lt;0.05; **p&lt;0.01; ***p&lt;0.001 vs 0 h;  ++</span><span class="CharOverride-17">р</span><span class="CharOverride-14">&lt;0.01; +++p&lt;0.001 vs 4 h; §§ p &lt;0.01 vs 24 h; vv </span><span class="CharOverride-17">р</span><span class="CharOverride-14">&lt;0.01 vs 48 h; ••• p&lt;0.001 vs 7 d</span></p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-14">Between-group level of significance: </span><span class="CharOverride-10">1</span><span class="CharOverride-14"> p&lt;0.05;</span><span class="CharOverride-10"> 2</span><span class="CharOverride-14"> p&lt;0.01; </span><span class="CharOverride-17">а</span><span class="CharOverride-14"> – vs control group; </span><span class="CharOverride-10">b</span><span class="CharOverride-14"> – vs group 0 </span></p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1"><span class="CharOverride-18"><a id="Table-2-"></a>Table 2:</span><span class="CharOverride-19"> Blood neutrophil/lymphocyte ratio in controls, dogs with experimental skin </span><span class="CharOverride-20">P. aeruginosa</span><span class="CharOverride-19"> infection - group 0 (untreated) and treated: group I (antibiotic), group II (Feverfew); group III (antibiotic+Feverfew). Values are means ± SD of five dogs in each group     </span></p>
			<table width="657" height="384" class="Table-Style-1" id="table-2">
				<colgroup>
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-5" />
					<col class="_idGenTableRowColumn-15" />
				</colgroup>
				<tbody>
					<tr class="_idGenTableRowColumn-7">
						<td />
						<td />
						<td colspan="4">
							<p class="Basic-Paragraph"><span class="CharOverride-15">Groups</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td />
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">Control</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">0 group               </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">I group                </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">II group                </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">III group        </span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-7">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">0h</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.04±0.34            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.53±1.32            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.63±0.43            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.67±1.65            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">1.72±0.91</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">4 h          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.59±0.18                        </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">3.38±1.35            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.19±1.80</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.26±1.04          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.03±2.52</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">24h          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.53±0.72           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">3.88±2.81            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">7.90±1.98 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">**            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">11.44±5.66 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">**a2b1       </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.28±2.63</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">48 h         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">1.92±0.21           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.21±3.84                         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">6.30±2.72           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">7.17±2.68            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">4.72±2.56</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-7">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">72 h         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.36±0.30          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.08±2.64             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">6.23±2.88           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">5.76±4.09            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">3.51±1.35</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">7 d           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.66±0.94          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">3.46±1.70            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">4.05±1.70           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">4.34±2.77 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">§            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.14 ± 1.34</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">10 d         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.33±0.17          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.85±1.23            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.88±0.90                                 </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.64±0.58 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">§§           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.70±1.53   </span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">14 d         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.58±0.46          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">1.88±0.76            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">1.78±0.62 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">§§§v           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">3.10±1.11 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">§§             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">2.78± 2.49</span></p>
						</td>
					</tr>
				</tbody>
			</table>
			<p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-14">Within-group level of significance: * p&lt;0.05; **p&lt;0.01; ***p&lt;0.001 vs 0 h; § p&lt;0.05; §§ p &lt;0.01; §§§ p&lt;0.001 vs 24 h; v p&lt;0.05 vs 48 h </span></p>
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-14">Between-group level of significance:</span><span class="CharOverride-10"> 1</span><span class="CharOverride-14"> p&lt;0.05; </span><span class="CharOverride-10">2</span><span class="CharOverride-14"> p&lt;0.01; </span><span class="CharOverride-21">а</span><span class="CharOverride-14"> – vs control group; </span><span class="CharOverride-10">b</span><span class="CharOverride-14"> – vs group 0 </span></p>
            <p class="Body-Text ParaOverride-1">&nbsp;</p>
            <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">DISCUSSION</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">The opportunistic Gram-negative bacterium <span class="CharOverride-7">P. aeruginosa</span> is a major pathogen, causing both local and generalised infections (<a href="#Van-Delden-C--2007-."><span class="Hyperlink">Van Delden, 2007</span></a>). The proper functioning of natural skin defense mechanisms – barrier systems, cellular and humoral elements, non-specific responses – inflammation, acute phase response, phagocytosis, guarantee the discontinuation of infection during the acute phase, when adaptive immunity is not yet realized (<a href="#Meglio-P--Gayathri-D--Perera-K--Nestle-OF--2011"><span class="Hyperlink">Meglio et al., 2011</span></a>). The pathogenesis of <span class="CharOverride-7">Pseudomonas aeruginosa</span> appears to be complex and multifactorial, impeding the application of the pathogenetic therapeutic approach. The selection of a specific therapeutic strategy was aimed at restoration of the equilibrium in defense systems through elimination of unwanted responses. Our experimental model of canine skin <span class="CharOverride-7">P. aeruginosa</span> infection allowed to monitor <span class="CharOverride-7">in vivo</span> not only the systemic defense mechanisms during the development of infection (from the 4<span class="CharOverride-5">th</span> hour to the 14<span class="CharOverride-5">th</span> day) but also to evaluate occurring injuries as well as the efficacy of applied treatment. All dogs infected with <span class="CharOverride-7">P. aerugino</span><span class="CharOverride-7">sa</span> developed inflammation at the site of inoculation with typical swelling, reddening and induration of the area. The evaluation of inflammation strength is important as the extremely intense inflammation could provoke severe tissue damage and systemic effects - fever, induced by pro-inflammatory cytokines, metabolic and functional changes (<a href="#Lindestam-AC--2010"><span class="Hyperlink">Lindestam, 2010</span></a>), as well as haematological changes (<a href="#Andonova-M--Urumova-V--Petkova-B--Slavov-E--Dzhelebov-P--Chaprazov-T--Roidev-R----Borissov-I--2014-"><span class="Hyperlink">Andonova et al., 2014</span></a>). From this point of view, we sought some sensible biomarkers of inflammation, reacting even in patients with slight inflammatory response to the inoculated agent. The number of studies on inflammation biomarkers in the scientific literature is remarkable (<a href="#Lacour-AG--Gervaix-A--Zamora-SA--Vadas-L--Lombard-PR--Dayer-JM--Suter-S--2001"><span class="Hyperlink">Lacour et al., 2001</span></a>). The advantages of inflammation biomarkers studied in this experiment were availability of specimens and rapid assay, presence both in the acute and chronic stage of inflammation, possibility for reduction of the number of ordered clinical tests with respect to lowering costs without compromising the quality of information. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			
			<p class="Figure--and-Table-Heading ParaOverride-1"><span class="CharOverride-6"><a id="Table-3-"></a>Table 3: </span>Rectal temperatute (C) in controls, dogs with experimental skin <span class="CharOverride-7">P. aeruginosa</span> infection - group 0 (untreated) and treated: group I (antibiotic), group II (Feverfew); group III (antibiotic+Feverfew). Values are means ± SD of five dogs in each group</p>
			<table width="657" height="338" class="Table-Style-1" id="table-3">
				<colgroup>
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-17" />
					<col class="_idGenTableRowColumn-18" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-19" />
					<col class="_idGenTableRowColumn-20" />
				</colgroup>
				<tbody>
					<tr class="_idGenTableRowColumn-7">
						<td />
						<td />
						<td colspan="4">
							<p class="Basic-Paragraph"><span class="CharOverride-15">Groups</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td />
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">Control</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">0 group               </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">I group                </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">II group                </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-15">III group        </span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-7">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">0h</span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.8±0.24            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.6±0.62           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.2±0.38            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.6±0.22           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.8±0.32</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">4 h          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.7±0.20             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">40.0±0.48 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a3***                                                                                  </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.7±0. 38 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a2***            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">40.0±0.40</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a3**         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.7±0.54 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a1*</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">24h          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.7±0.13            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">40.3±0.37</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">***           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.4±0.63</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">**             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">40.2±0.58</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">***          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.8±0.24</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">*</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-10">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">48 h         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.6±0.28           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">40.3±0.36 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">***                                       </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.4±0.58 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">**            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.2±0.47</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">**          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.6±0.38</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-9">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">72 h         </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.7±0.50            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.5±15.0 </span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">a1e1*§v           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.3±0.24</span></p>
							<p class="Basic-Paragraph"><span class="CharOverride-16">**            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">39.4±0.50           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.8±0.35</span></p>
						</td>
					</tr>
					<tr class="_idGenTableRowColumn-8">
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">7 d           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.7±0.46            </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.8±0.27          </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.8±0.38             </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.6±0.70           </span></p>
						</td>
						<td>
							<p class="Basic-Paragraph"><span class="CharOverride-16">38.6±0.50</span></p>
						</td>
					</tr>
				</tbody>
			</table>
			<p class="Figure--and-Table-Heading ParaOverride-1">&nbsp;</p>
			<p class="Figure--and-Table-Heading ParaOverride-1">Within-group level of significance: * p&lt;0.05; **p&lt;0.01; ***p&lt;0.001 vs 0 h; § p&lt;0.05 vs 24 h; v p&lt;0.05 vs 48 h </p>
			<p class="Figure--and-Table-Heading ParaOverride-1">Between-group level of significance: <span class="CharOverride-6">1</span> p&lt;0.05; <span class="CharOverride-6">2</span> p&lt;0.01; <span class="CharOverride-22">а</span> – vs control group; <span class="CharOverride-6">e</span> – vs group III</p>
			<p class="Body-Text">&nbsp;</p>
			<p class="Body-Text">&nbsp;</p>
			<p class="Body-Text">In their analysis of inflammatory response to infection and having reviewed the molecular biology of inflammation and sepsis, <a href="#Cinel-I--Opal-SM--2009-."><span class="Hyperlink">Cinel and Opal (2009)</span></a> emphasised the key position of NF-<span class="CharOverride-8">к</span>B. NF-<span class="CharOverride-8">к</span>B is one of the most important transcription factors with a potential for regulation of a number of biological processes – inflammation, acute phase response, immune response (<a href="#Hayden-MS--West-AP--Ghosh-S--2006"><span class="Hyperlink">Hayden et al., 2006</span></a>). <a href="#Cigana-C--Lor-e-NI--Bernardini-ML--Bragonzi-A--2011-."><span class="Hyperlink">Cigana et al. (2011)</span></a><span class="CharOverride-7"> </span>outlined that via NF-<span class="CharOverride-8">к</span>B activation, <span class="CharOverride-7">P. aeruginosa</span> stimulates proinflammatory cytokine production. Our <span class="CharOverride-7">in vivo</span> experiments with <span class="CharOverride-7">P. aeruginosa</span> demonstrated 2-3 times higher serum NF-<span class="CharOverride-8">к</span>B concentrations as early as the 24<span class="CharOverride-5">th</span> hour after inoculation in dogs from groups 0 and I (<a href="#Figure-1-"><span class="Hyperlink">Figure 1</span></a>). This confirms that NF-<span class="CharOverride-8">к</span>B could be a reliable marker in skin infections, which is also seen from the fact that its levels persisted high even by the 10<span class="CharOverride-5">th</span> day in untreated dogs. The key signalling pathway triggered by <span class="CharOverride-7">P. aeruginosa </span>could be hardly distinguished in <span class="CharOverride-7">in vivo</span> studies, as the pathogen uses multiple virulence factors to attack the host and alters them in the course of the infection. Furthermore, the presence of <span class="CharOverride-7">P. aeruginosa</span> in the area of intense inflammation induces genotypic variation in the toxins, exoenzymes, secretion systems and surface structures, and thus, significant changes in the relationships between bacterial cells and host structures (<span class="Hyperlink">Cigana et al., 2011</span>; <a href="#Lavoie-EG--Wangdi-T--Kazmierczak-B--2011"><span class="Hyperlink">Lavoie et al., 2011</span></a>). On the other hand, the impact of <span class="CharOverride-7">P. aeruginosa</span> is characterised with numerous processes at molecular, cellular and organism levels and abundance of complex regulatory interactions. Despite that, <a href="#Tak-PP--Firestein-GS--2001"><span class="Hyperlink">Tak and Firestein (2001)</span></a> reported that NF-<span class="CharOverride-8">к</span>B is a crucial regulator of inflammation, and <a href="#Koprowska-K--Czyz-M--2010-."><span class="Hyperlink">Koprowska and Czyz (2010)</span></a> established the possibility for inhibition of NF-<span class="CharOverride-8">к</span>B activity by parthenolide. On the basis of these facts, we have used the natural product Feverfew for control of inflammation in <span class="CharOverride-7">P. aeruginosa-</span>infected dogs. The duration of intake was aimed at a moderate NF-<span class="CharOverride-8">к</span>B inhibition. The resulting effect was proved by the lack of statistically significant deviations in NF-<span class="CharOverride-8">к</span>B values in dogs receiving the phytopreparation (group II and III). This was also true for dogs from group I, where the variations in blood NF-<span class="CharOverride-8">к</span>B values were insignificant between post infection days 7 and 10. Dogs from this group were on 10-day antibiotic therapy initiated on the 48<span class="CharOverride-5">th</span> hour after the infection with <span class="CharOverride-7">P. aeruginosa</span>, but the specific effect was observed on the 5<span class="CharOverride-5">th</span> day of antibiotic therapy. Enrofloxacin penetrates well in tissues, has a continuous post antibiotic effect against <span class="CharOverride-7">P. aeruginosa</span> (<a href="#Sarkozy-G--2001-"><span class="Hyperlink">Sarkozy, 2001</span></a>) and is effective against bacterial strains multiresistant to convenient antimicrobial drugs. <span class="cit-auth2">The drug is also able to </span><span class="Hyperlink CharOverride-23">enhance the formation of neutrophil extracellular traps</span> (<a href="#Jerjomiceva-N--Seri-H--V-llger-L--Wang-Y--Zeitouni-N--Naim-HY--von-K-ckritz-Blickwede--M--2014"><span class="Hyperlink">Jerjomiceva et al., 2014</span></a>). </p>
		  <p class="Body-Text">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">NO appears to be an important element in the inflammatory process, being an endogenous regulator of vascular tone (<a href="#Cirino-G--Distrutti-E--Wallace-JL--2006-."><span class="Hyperlink">Cirino et al., 2006</span></a>; <a href="#Tripathi-P--Tripathi-Pr--Kashyap-L--Singh-V--2007"><span class="Hyperlink">Tripathi et al., </span></a><span class="Hyperlink">2007</span>). In healthy subjects its blood levels are influenced by the gender, age, and nutrition (<a href="#Ghasemi-A--Zahediasl-S--2011-."><span class="Hyperlink">Ghasemi and Zahediasl, 2011</span></a>). In our experimental model, the impact of these factors was reduced to a minimum. In the present study, NO concentrations increased as early as the 4<span class="CharOverride-5">th</span> hour after s.c. inoculation of <span class="CharOverride-7">P. aeruginosa </span>(<a href="#Table-1-"><span class="Hyperlink">Table 1</span></a>). This increase was most probably due to enhance NO production by cell elements at the inoculation site (<a href="#Tripathi-P--Tripathi-Pr--Kashyap-L--Singh-V--2007"><span class="Hyperlink">Tripathi et al., 2007</span></a>). Serum NO concentration after the 4<span class="CharOverride-5">th</span> hour in dogs with antibiotic therapy (group I), as well as in dogs on phytotherapy with Feverfew were reduced. This could be due to the applied treatments, as well as to their effects on NF-kB (<a href="#Figure-1-"><span class="Hyperlink">Figure 1</span></a>), which is able to control NOS activity (<a href="#Cirino-G--Distrutti-E--Wallace-JL--2006-."><span class="Hyperlink">Cirino et al., 2006</span></a>). By the end of the study period – 14<span class="CharOverride-5">th</span> day, serum NO concentrations were higher in all experimental dogs compared to controls (<a href="#Table-1-"><span class="Hyperlink">Table 1</span></a>). This is a clear attestation for the role of NO in immune mechanisms associated with adaptive immunity. <a href="#Tripathi-P--Tripathi-Pr--Kashyap-L--Singh-V--2007"><span class="Hyperlink">Tripathi et al. (2007</span></a><span class="Hyperlink">)</span> commented on the role of NO for specific immunity and discussed its influence on the Th1/Th2 ratio. The observed biphasic increase in serum NO concentrations in the early and late stage of infection development emphasise its significance for both non-specific and specific defense mechanisms. With this regard, the N/L ratio could also provide some information, although limited. <a href="#Celikbilek-A--Ismailogullari-S--Zararsiz-G--2014-."><span class="Hyperlink">Celikbilek et al. (2014</span></a>) believe that N/L ratio is a simple and easily available marker of subclinical inflammation, while <a href="#Ishimine-N--Honda-T--Yoshizawa-A--Kawasaki-K--Sugano-M--Kabayashi-Y--Matsumoto-T--2013-."><span class="Hyperlink">Ishimine et al. (2013)</span></a> associated its alterations in combination with other parameters. Our data were comparable to those, showing a marked increase in N/L ratios between post infection hours 4 and 72 in all <span class="CharOverride-7">P</span><span class="CharOverride-7">. aeruginosa</span>-infected dogs (<a href="#Table-2-"><span class="Hyperlink">Table 2</span></a>). Dogs treated with Feverfew (group II) showed the most remarkable increase in N/L ratios, which could result from the effects of phytopreparation on blood circulation. Parthenolide (the major sesquiterpene lactone in medicinal plant Feverfew) action does not appear to be limited to a single mechanism. Plant extracts affect a wide variety of physiologic pathways. Some of these mechanisms have been discussed previously.</p>
			<p class="Body-Text ParaOverride-1">&nbsp;</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">Conclusion and Clinical Implications</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The inoculation of <span class="CharOverride-7">P. Aeruginosa</span> in dogs provoked an inflammatory response accompanied with changes in serum NF-<span class="CharOverride-8">к</span>B and NO concentrations, as well as of blood N/L ratio. These parameters could be utilised in clinical practice not only for characterisation of inflammatory response to skin infections. The use of Feverfew with active principle parthenolide, applied at the very beginning of infection/inflammation response inhibits effectively NF-<span class="CharOverride-8">к</span>B, which justifies its application in dogs as anti-inflammatory agent. Extensive large-scale clinical investigations for elucidation of effects on host defense – innate and immune systems as other protective cellular responses are however needed. This approach does not guarantee eradication of the pathogen. The applied complementary therapy with antibiotic against the pathogen combined with phytotherapy for host response modulation in the tested experimental model, yields good and promising results.  </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">ACKNOWLEDGEMENTS</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">Our heartiest thanks to Mrs Daniela Ivanova, Faculty of Veterinary Medicine, for her technical assistance in preparing this manuscript.</p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">CONFLICT OF INTEREST</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Body-Text ParaOverride-1">The authors declare that there is no conflict of interests in this manuscript. </p>
		  <p class="Body-Text ParaOverride-1">&nbsp;</p>
			<p class="Heading-1--Introduction----">REFERENCES</p>
		  <p class="Heading-1--Introduction----">&nbsp;</p>
			<p class="Heading-1--Introduction----"> </p>
			
				<li class="References ParaOverride-3" lang="en-US"><a id="Angus-DC--2011-"></a><a id="Andonova-M--Urumova-V--Petkova-B--Slavov-E--Dzhelebov-P--Chaprazov-T--Roidev-R----Borissov-I--2014-"></a>Andonova M, Urumova V, Petkova B, Slavov E, Dzhelebov P, Chaprazov T, Roidev R,   Borissov I (2014). Haematological and biochemical parameters characterizing the   progression of experimental <span class="CharOverride-7">Pseudomonas aeruginosa </span>skin infection in dogs. Bulg. J. Vet. Med. 17(1): 32 - 41<span class="CharOverride-7">.</span></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Breidenstein-E--Fuente-Ninez-C--Hancock-R--2011"></a>Angus DC (2011). The search for effective therapy for sepsis: back to the drawing board?  JAMA. 306: 2614 - 2615. <a href="http://dx.doi.org/10.1001/jama.2011.1853"><span class="Hyperlink">http://dx.doi.org/10.1001/jama.2011.1853</span></a></li>
				<li class="References ParaOverride-3" lang="en-US">Breidenstein E, Fuente-Ninez C, Hancock R (2011). <span class="CharOverride-7">Pseudomonas aeruginosa</span>: all roads lead to resistance. Trends Microbiol. 19(8): 419 - 426. <a href="http://dx.doi.org/10.1016/j.tim.2011.04.005"><span class="Hyperlink">http://dx.doi.org/10.1016/j.tim.2011.04.005</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Celikbilek-A--Ismailogullari-S--Zararsiz-G--2014-."></a>Celikbilek A, Ismailogullari S, Zararsiz G (2014). <span class="Hyperlink CharOverride-23">Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J. Clin. Lab. Anal. 28(</span><span class="Hyperlink CharOverride-23">1</span><span class="Hyperlink CharOverride-23">): 27 - 31</span>. <a href="http://dx.doi.org/10.1002/jcla.21639"><span class="Hyperlink">http://dx.doi.org/10.1002/jcla.21639</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Cigana-C--Lor-e-NI--Bernardini-ML--Bragonzi-A--2011-."></a>Cigana C, Lor`e NI, Bernardini ML, Bragonzi A (2011). Dampening host sensing and avoiding Recognition in <span class="CharOverride-7">Pseudomonas aeruginosa</span> Pneumonia. J. Biomed. Biotechnol. Article ID&#160;852513, <a href="http://dx.doi.org/10.1155/2011/852513"><span class="Hyperlink">http://dx.doi.org/10.1155/2011/852513</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Cinel-I--Opal-SM--2009-."></a>Cinel I, Opal SM (2009). Molecular Biology of inflammation and sepsis. Primer.  Crit. Care   Med. 37(1): 291 - 304. <a href="http://dx.doi.org/10.1097/CCM.0b013e31819267fb"><span class="Hyperlink">http://dx.doi.org/10.1097/CCM.0b013e31819267fb</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Cirino-G--Distrutti-E--Wallace-JL--2006-."></a>Cirino G, Distrutti E, Wallace JL (2006). Nitric oxide and inflammation. Inflamm. Allergy–Drug Targets. 5(2): 115 - 119. <a href="http://dx.doi.org/10.2174/187152806776383143"><span class="Hyperlink">http://dx.doi.org/10.2174/187152806776383143</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Farah-R--Khamisy-Farah-R--2014-"></a>Farah R, Khamisy-Farah R (2014). Association of neutrophil to lymphocyte ration with presence and severity of gastric due to <span class="CharOverride-7">Helicobacter pylori</span> infection. J. Clin. Lab. Anal. 28(3): 219 - 223. <a href="http://dx.doi.org/10.1002/jcla.21669"><span class="Hyperlink">http://dx.doi.org/10.1002/jcla.21669</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Ghasemi-A--Zahediasl-S--2011-."></a>Ghasemi A, Zahediasl S (2011). Is Nitric Oxide a Hormone? Iranian Biomed. J. 15(3): 59-65.        </li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Hayden-MS--West-AP--Ghosh-S--2006"></a>Hayden MS, West AP, Ghosh S<span class="CharOverride-6"> </span>(2006). NF-kappaB and the immune response. Oncogene. 25(51): 6758 - 6780. <a href="http://dx.doi.org/10.1038/sj.onc.1209943"><span class="Hyperlink">http://dx.doi.org/10.1038/sj.onc.1209943</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Ishimine-N--Honda-T--Yoshizawa-A--Kawasaki-K--Sugano-M--Kabayashi-Y--Matsumoto-T--2013-."></a>Ishimine N, Honda T, Yoshizawa A, Kawasaki K, Sugano M, Kabayashi Y, Matsumoto T (2013). Combination of white blood cell count and left shift level real-timely reflects a course of bacterial infection. J. Clin. Lab. Anal. 27(5): 407 - 411. <a href="http://dx.doi.org/10.1002/jcla.21619"><span class="Hyperlink">http://dx.doi.org/10.1002/jcla.21619</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><span class="yiv5180340236autoren"><a id="Jerjomiceva-N--Seri-H--V-llger-L--Wang-Y--Zeitouni-N--Naim-HY--von-K-ckritz-Blickwede--M--2014"></a>Jerjomiceva&#160;N, Seri&#160;H</span><span class="yiv5180340236color">, </span><span class="yiv5180340236autoren">Völlger&#160;L, Wang&#160;Y, Zeitouni&#160;N, Naim&#160;HY, von Köckritz-Blickwede  M (2014).&#160;</span><span class="Hyperlink CharOverride-23">Enrofloxacin enhances the formation of neutrophil extracellular traps in bovine granulocytes</span>. J. Innate Immun. 6(5): 706 - 712. <a href="http://dx.doi.org/10.1159/000358881"><span class="Hyperlink">http://dx.doi.org/10.1159/000358881</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Kipnis-E--Sawa-T--Wiener-Kronosh-J--2006"></a>Kipnis E, Sawa T, Wiener-Kronosh J (2006). Targeting mechanisms of <span class="CharOverride-7">Pseudomonas aeruginosa</span> pathogenesis. Medicine and Maladies Infectieuses. 36(2): 78 - 91.</li>
				<li class="References ParaOverride-3" lang="en-US"><span class="Hyperlink CharOverride-23"><a id="Koprowska-K--Czyz-M--2010-."></a>Koprowska K</span>, <span class="Hyperlink CharOverride-23">Czyz M</span> (2010). Molecular mechanisms of parthenolide’s action: Old drug with a new face. <span class="Hyperlink CharOverride-23">Postepy Hig. Med. Dosw. </span>64(5): 100 - 114.</li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Kumar-H--Kawai-T--Akira-S--2011"></a>Kumar H, Kawai T, Akira S (2011). Pathogen recognition by the innate immune system. Int.  Rev. Immunol. 30(1): 16 - 34. <a href="http://dx.doi.org/10.3109/08830185.2010.529976"><span class="Hyperlink">http://dx.doi.org/10.3109/08830185.2010.529976</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Lacour-AG--Gervaix-A--Zamora-SA--Vadas-L--Lombard-PR--Dayer-JM--Suter-S--2001"></a>Lacour AG, Gervaix A, Zamora SA, <span class="Hyperlink CharOverride-23">Vadas</span> L, <span class="Hyperlink CharOverride-23">Lombard PR, </span>Dayer JM, Suter S (2001).  Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur. J. Pediat. 160(2): 95 - 100. <a href="http://dx.doi.org/10.1007/s004310000681"><span class="Hyperlink">http://dx.doi.org/10.1007/s004310000681</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Lavoie-EG--Wangdi-T--Kazmierczak-B--2011"></a>Lavoie EG, Wangdi T, Kazmierczak B (2011). Innate immune response to <span class="CharOverride-7">Pseudomonas aeruginosa</span> infection. Microb. Infect. 13(14-15): 1133-1145. <a href="http://dx.doi.org/10.1016/j.micinf.2011.07.011"><span class="Hyperlink">http://dx.doi.org/10.1016/j.micinf.2011.07.011</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Lindestam-AC--2010"></a>Lindestam AC (2010). Intracellular triggering of inflammation by the extracellular bacterium <span class="CharOverride-7">Pseudomonas aeruginosa. </span>PhD thesis. Glasgow Theses Service.  <a href="mailto:http://theses.gla.ac.uk/theses@gla.ac.uk"><span class="Hyperlink">http://theses.gla.ac.uk/theses@gla.ac.uk</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Mantovani-A--Cassatella-MA--Costantini-C--Jaillon-S--2011-."></a>Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011). Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11(8): 519 - 531. <a href="http://dx.doi.org/10.1038/nri3024"><span class="Hyperlink">http://dx.doi.org/10.1038/nri3024</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Mathema-VB--Young-Sang-K--Balkrishna-CT--Mika-S--2012-."></a>Mathema VB, Young-Sang K, Balkrishna CT, Mika S (2012). Parthenolide, a Sesquiterpene Lactone, Expresses Multiple Anti-cancer and Anti-inflammatory Activities. Inflammation.  35(2): 560-565. <a href="http://dx.doi.org/10.1007/s10753-011-9346-0"><span class="Hyperlink">http://dx.doi.org/10.1007/s10753-011-9346-0</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Meglio-P--Gayathri-D--Perera-K--Nestle-OF--2011"></a>Meglio P, Gayathri D, Perera K, Nestle OF (2011). The multitasking organ: recent insights into skin immune function. Immunity. 35(6): 857 - 869. <a href="http://dx.doi.org/10.1016/j.immuni.2011.12.003"><span class="Hyperlink">http://dx.doi.org/10.1016/j.immuni.2011.12.003</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Miranda-K--Espey-MG--Wink-DA--2001-."></a>Miranda K, Espey MG, Wink DA (2001). A rapid, simple spectrophotometric method for detection of nitrate and nitrite.<span class="CharOverride-7"> </span>Nitric Oxide. 5(1): 62 - 71. <a href="http://dx.doi.org/10.1006/niox.2000.0319"><span class="Hyperlink">http://dx.doi.org/10.1006/niox.2000.0319</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Paur-I--Austena-LM--Blomhoff-R--2008"></a>Paur I, Austena LM, Blomhoff R (2008). Extracts of dietary plants are efficient modulators of nuclear factor kappa B. Food Chem. Toxicol. 26(4): 1288 - 1297. <a href="http://dx.doi.org/10.1016/j.fct.2007.09.103"><span class="Hyperlink">http://dx.doi.org/10.1016/j.fct.2007.09.103</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Quinn-PJ--Carter-ME--Markey-BK--Carter-GR--1999-"></a>Quinn PJ, Carter ME, Markey BK, Carter GR (1999). Bacteriology. <span class="CharOverride-7">Pseudomonas </span>species. In: Clinical Veterinary Microbiology, Harcourt Publishers, section 2.  237 – 243.</li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Rahman-M--McFadden-G--2011"></a>Rahman M, McFadden G (2011). Modulation of NF-<span class="CharOverride-8">κ</span>B signalling by microbial pathogens.  Nat. Rev. Microbiol. 9(4): 291 - 306. <a href="http://dx.doi.org/10.1038/nrmicro2539"><span class="Hyperlink">http://dx.doi.org/10.1038/nrmicro2539</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Sarkozy-G--2001-"></a>Sarkozy G (2001). Quinolones: a class of antimicrobial agents. Veterinarni Medicina-Czech. 46(9): 257 - 274.</li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Sprucek-F--Toman-M--Faldyna-M--Svoboda-M--2007"></a>Sprucek F, Toman M, Faldyna M, Svoboda M (2007). Immunologic indicators in dogs affected by deep pyoderma. Acta Vet. Brno. 76(2): 283 - 290. <a href="http://dx.doi.org/10.2754/avb200776020283"><span class="Hyperlink">http://dx.doi.org/10.2754/avb200776020283</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Tak-PP--Firestein-GS--2001"></a>Tak PP, Firestein GS (2001). NF-kappa B: A key role in inflammatory diseases. J. Clin.     Invest. 107(1): 7-11. <a href="http://dx.doi.org/10.1172/JCI11830"><span class="Hyperlink">http://dx.doi.org/10.1172/JCI11830</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Tilstra-JS--Clauson-CL--Niedernhofer-LJ--Robbins-PD--2011-."></a>Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD (2011). NF-kB in aging and disease.  Rev. Aging Dis. 2(6): 449 - 465.</li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Tripathi-P--Tripathi-Pr--Kashyap-L--Singh-V--2007"></a>Tripathi P, Tripathi Pr, Kashyap L, Singh V (2007). The role of nitric oxide in inflammatory reactions. FEMS Immunol. Med. Microbiol. 51(3): 443 - 452. <a href="http://dx.doi.org/10.1111/j.1574-695X.2007.00329.x"><span class="Hyperlink">http://dx.doi.org/10.1111/j.1574-695X.2007.00329.x</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Van-Delden-C--2007-."></a>Van Delden C (2007). <span class="CharOverride-7">Pseudomonas aeruginosa</span> infections: how should we treat them? Int. J.  Antimicrob. Agents. 30(Suppl 1): S71 - 75. <a href="http://dx.doi.org/10.1016/j.ijantimicag.2007.06.015"><span class="Hyperlink">http://dx.doi.org/10.1016/j.ijantimicag.2007.06.015</span></a></li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Vitiello-M--Galdiero-M--Finamore-E--Galdiero-S--Galdiero-M--2012"></a>Vitiello M, Galdiero M, Finamore E, Galdiero S, Galdiero M (2012). NF-kB as a potential therapeutic target in microbial diseases. Mol. Bio. Syst. 8(4): 1108-1120. <a href="http://dx.doi.org/10.1039/c2mb05335g"><span class="Hyperlink">http://dx.doi.org/10.1039/c2mb05335g</span></a></li>
		  <li class="References ParaOverride-3" lang="en-US"><a id="Xie-QW--Kashiwabara-Y--Nathan-C--1994"></a>Xie QW, Kashiwabara Y, Nathan C (1994). Role of transcription factor -NF-kappaB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269(7): 4705 - 4708.</li>
				<li class="References ParaOverride-3" lang="en-US"><a id="Yang-Q--Ghose-P--Ismaila-N--2013"></a><a id="Yang-Q--Ghose-P--Ismaila-N--2013-"></a>Yang Q, Ghose P, Ismaila N (2013). Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infec. Immun. 81(5): 1751 - 1763.</li>
                <p>&nbsp;</p>
                <p>&nbsp;</p>
                <p>&nbsp;</p>
			
		</div>
	</body>
</html>
